Document is current
Any future updates will be listed below
-
Authors
Rego, Ryan T.
Zhukov, Yuri
Reneau, Kyrani A.
Pienta, Amy
Rice, Kristina L.
Brady, Patrick
Siwo, Geoffrey H.
Wachira, Peninah Wanjiku
Abubakar, Amina
Kollman, Ken
Waljee, Akbar K.
-
Funding
Funding for this research was provided by:
University of Michigan Center for Global Health Equity
National Institutes of Health (U54TW012089, U54TW012089, U54TW012089, U54TW012089)
- License Information
-
More Information
Article History
Received: 31 October 2022
Accepted: 31 October 2023
First Online: 24 November 2023
Declarations
:
: This study utilized secondary, publically available data from the World Bank Group. As part of collection of these data, the World Bank Group had a comprehensive ethics and consenting process. More information can be found from the data source [CitationRef removed].
: Na.
: GHS is a founder of Anza Biotechnologies and holds equity in Helix Nanotechnologies. All other authors have no competing interests.
